NCT02456571View on ClinicalTrials.gov

CTC Immune Checkpoint

CompletedOBSERVATIONAL

Enrollment

38

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

June 13, 2019

Study Completion Date

June 13, 2019

Conditions

Prostate Cancer

Interventions

DEVICE

CTC biomarker expression prevalence

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

collaborator

Janssen Research & Development, LLC

INDUSTRY

lead

Duke University

OTHER